MDM2 and neoplasm: While the accumulated mutp53 escapes from MDM2-mediated degradation, it can still be degraded in a MDM2-independent and proteasome-dependent pathway, generating peptides that are eventually presentated on tumor cell surface by class I molecules of the major histocompatibility comples (MHC).